Submission of Matters to a Vote of Security Holders (Form 8-K)

LogicBio Therapeutics, Inc. (the 'Company') held its Annual Meeting of Stockholders on June 11, 2021. The stockholders (i) elected three Class III directors to the Company's Board of Directors (the 'Board') to serve until the 2024 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal; and (ii) ratified the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021.

(i) The Class III directors elected to the Board, as well as the number of votes for, votes withheld, abstentions and broker non-votes with respectto each of these individuals, are set forth below:

(ii) The proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021 received the following votes: